Why the study?
Does intravenous thrombolysis reduce the incidence and evolution of late potentials in patients after acute myocardial infarction?
Does intravenous thrombolysis reduce the incidence and evolution of late potentials in patients after acute myocardial infarction?
Intravenous thrombolysis prevents the increase in late potentials on signal-averaged ECGs within 10 days post-myocardial infarction, potentially explaining its mortality benefit by reducing arrhythmic risk.
Thrombolysis may limit late-potential evolution after MI; leaves open whether this mediates arrhythmic risk reduction.
Patients with late potentials in the signal averaged electrocardiogram are more at risk of lethal arrhythmias in the period after acute myocardial infarction. To test the effects of thrombolysis on the incidence and evolution of late potentials, 158 consecutive patients were prospectively studied during the first 10 days after acute myocardial infarction. The study population consisted of two groups: 93 control patients treated conservatively and 65 patients treated with intravenous thrombolysis. Recordings of signal averaged electrocardiogram were obtained within two days and 7-10 days after infarction. The incidence of late potentials in the first two days after infarction was not significantly different in the thrombolytic and control groups (14% v 11.8%). By 7-10 days the incidence of late potentials among patients who underwent thrombolysis remained unchanged (14%); however, it increased significantly in the control group (11.8% to 22.5%). Thus thrombolysis seems to reduce the evolution of late potentials within 10 days of infarction. Because the risk of fatal arrhythmias is higher in patients with late potentials this study may partly explain the reduced mortality after thrombolysis.
No takes yet. Share an insight, caveat, or question.
Eldar et al. (1990) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: